biogen.com (BIIB) Tezkor likvidlik koeffitsiyenti

Biogen Inc. - BIIB emitenti grafik logotipi

Biogen Inc. (BIIB) kompaniyasining yangi rahbariyati xarajatlarni optimallashtirish va shaffof loyihalar portfeli orqali o'sishni tiklashni maqsad qilgan. Joriy likvidlikni monitoring qilish ushbu harakatlarni tasdiqlaydi, bunda joriy ko'rsatkich 1.31 ga tengdir. Sinovdan o'tgan nevrologik davolash usullari barqaror pul oqimini ta'minlaydi. Shu bilan birga, kompaniya arzon generik dori vositalarining bosimidan bozor ulushini himoya qilish uchun innovatsion Altsgeymer patentlarini joriy qilmoqda.

Biogen Corp (BIIB) - Oraliq qoplama koeffitsiyenti 04.07.2022dan 29.10.2026gacha

biogen.com (BIIB) kompaniyasi koʻrsatkichlari kesimi va tahlili

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Narx grafigi Biogen Corp|BIIB - Oʻrtacha prognoz narxi
- bozor kapitallashuvi tafsilotlari:
Bozor kapitallashuvi Biogen Corp|BIIB - Kompaniyaning to‘liq qiymati
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati Biogen|BIIB - Biznesning balans bahosi|Bozor qiymatining balans qiymatiga nisbati biogen.com|BIIB - Kompaniya aktivlari
- qarz yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Biogen Inc.|BIIB - Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Biogen|BIIB - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Biogen Corp|BIIB - Kompaniyaning uzoq muddatli qarzdorligi|Kompaniyaning qisqa muddatli majburiyatlari Biogen|Tezkor likvidlik koeffitsiyenti biogen.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
BIIB - Sof moliyaviy natija
Kompaniyaning har tomonlama tahlili:Biogen Inc.
biogen.com yetakchi tovari

Tezkor likvidlik kompaniyaning illikvid zaxiralarni butunlay e'tiborsiz qoldirgan holda, naqd pul va debitorlik qarzlari yordamida qisqa muddatli majburiyatlarni zudlik bilan to'lash qobiliyatini o'lchaydi. Biogen Inc. (BIIB) uchun ushbu rezerv juda muhimdir, chunki nevrologik dori vositalarini ishlab chiqishning xavfli jarayoni ilm-fanga ulkan xarajatlarni talab qiladi. Acid-test koeffitsiyenti dinamikasini tahlil qilish orqali investor potentsial klinik sinovlarning muvaffaqiyatsizligi yuzasidan biznesning haqiqiy xavfsizlik zaxirasini ko'radi. Ortiqcha likvidlik omon qolishni kafolatlaydi, ammo umumiy kapital rentabelligini kamaytirishi mumkin.

Muhim raqobatchilar

Neurocrine Biosciences Inc (NBIX) - Tezkor likvidlik|Shoshilinch likvidlik Regencell Corp (RGC)|AXSM (Axsome Therapeutics) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik ACAD|Tezkor likvidlik koeffitsiyenti XENE|Oraliq qoplama koeffitsiyenti Viking Therapeutics Inc|Tezkor likvidlik Supernus Pharma SUPN|Catalyst Corp (CPRX) - Shoshilinch likvidlik|Denali Therapeutics - Tezkor likvidlik koeffitsiyenti|Kritik likvidlik harmonybiosciences.com (HRMY)|BHVN: Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik Amylyx Pharmaceuticals Inc (AMLX)|Tezkor likvidlik Trevi Pharma|Shoshilinch likvidlik koeffitsiyenti PRAX (Praxis Corp)|Tezkor likvidlik ko‘rsatkichi AVXL (Anavex Life Sciences)|CBLL (ceribell.com) - Oraliq qoplash koeffitsiyenti|Tezkor likvidlik koeffitsiyenti PRTA (Prothena Corporation PLC)|Oraliq qoplama koeffitsiyenti Alector Inc. (ALEC)|ANNX - Tezkor likvidlik|OMER (Omeros Corporation) - Shoshilinch likvidlik koeffitsiyenti|NGNE: Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi acimmune.com|Tezkor likvidlik ko‘rsatkichi VYGR|Neumora (NMRA) - Oraliq qoplama koeffitsiyenti|Tezkor likvidlik koeffitsiyenti SCLX|Tezkor likvidlik TVGN (Tevogen Bio Inc.)|Tezkor likvidlik koeffitsiyenti ACOG (Alpha Cognition Inc.)|Oraliq qoplama koeffitsiyenti Cognition Therapeutics Inc. (CGTX)|Inhibikase Therapeutics, Inc. - Tezkor likvidlik koeffitsiyenti|Oraliq qoplama koeffitsiyenti Cassava Sciences Inc SAVA|ASRT: Tezkor likvidlik koeffitsiyenti|COYA (Coya Therapeutics) - Tezkor likvidlik|Tezkor likvidlik VistaGen Therapeutics, Inc.|Shoshilinch likvidlik koeffitsiyenti OVID (Ovid Rx)|Tezkor likvidlik koeffitsiyenti ABOS|CRVO - Shoshilinch likvidlik|Alterity Therapeutics Limited - Tezkor likvidlik ko‘rsatkichi|Tezkor likvidlik koeffitsiyenti Clene Inc CLNN|PEPG - Tezkor likvidlik|Oraliq qoplash koeffitsiyenti JUNS (Jupiter Neurosciences, Inc.)|Relmada Therapeutics, Inc. (RLMD) - Tezkor likvidlik|Shoshilinch likvidlik Annovis Bio Inc (ANVS)|GRCE (Grace Therapeutics Inc) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik AIFF|Tezkor likvidlik koeffitsiyenti KLTO|Oraliq qoplama koeffitsiyenti neurosense-tx.com|Tezkor likvidlik Reviva Pharmaceuticals Holdings, Inc. RVPH|MetaVia Inc. (MTVA) - Shoshilinch likvidlik|NeurAxis, Inc - Tezkor likvidlik koeffitsiyenti|Kritik likvidlik Helius Medical (HSDT)|PASG: Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik Neuphoria Therapeutics (NEUP)|Tezkor likvidlik Minerva Neurosciences, Inc.|Shoshilinch likvidlik koeffitsiyenti ATHA (Athira Pharma Inc)|Tezkor likvidlik ko‘rsatkichi ADXN (Addex Therapeutics, Ltd.)|ALZN (alzamend.com) - Oraliq qoplash koeffitsiyenti|Tezkor likvidlik koeffitsiyenti CYCN (Cyclerion Therapeutics, Inc.)|Oraliq qoplama koeffitsiyenti Protagenic Therapeutics Inc. (PTIX)|KTTA - Tezkor likvidlik|CRGT (Cortigent, Inc.) - Shoshilinch likvidlik koeffitsiyenti|ATXI: Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi BrainStorm Cell Therapeutics Inc.|Tezkor likvidlik ko‘rsatkichi CARA|chromocell.com (CHRO) - Oraliq qoplama koeffitsiyenti|Tezkor likvidlik koeffitsiyenti ELYM|Tezkor likvidlik ITCI (intracellulartherapies.com)|Tezkor likvidlik koeffitsiyenti LBPH (Longboard Pharma)|Oraliq qoplama koeffitsiyenti Marinus Pharma (MRNS)|NKGen Biotech, Inc. - Tezkor likvidlik koeffitsiyenti|Oraliq qoplama koeffitsiyenti neurobopharma.com NRBO|SAGE: Tezkor likvidlik koeffitsiyenti|SNPX (Synaptogenix Inc.) - Tezkor likvidlik|Tezkor likvidlik Trevena, Inc|Shoshilinch likvidlik koeffitsiyenti VIGL (Vigil Neuro)|Tezkor likvidlik koeffitsiyenti WENA|CERE - Shoshilinch likvidlik